Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Megan Haggan 29/09/2020

Debbie Rigby takes a look at the latest in research news Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure The EMPEROR-Reduced Trial compared empagliflozin (10 mg once daily) or placebo (in addition to recommended therapy) in 3730 patients with heart failure and an ejection fraction of 40% or less. Results show a lower risk

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Doctor title ‘recognition and respect you deserve’

A huge amount of John's comments are outright xenophobic. There is no point trying to reason with someone who thinks…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

Still not answering the question. Just building up more strawmen. If you're confident that you are correct then stop lying…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

The Guild doesn't "direct" anyone openly but they hold a lot of power and it's either nieve or disingenous to…

John Smith

Doctor title ‘recognition and respect you deserve’

I honestly don’t know why engage with such a childish response but I’ll give it one more go. I said…

John Smith

Research Roundup

Previous ‘Very, very lengthy delay’ torpedoes unfair dismissal case

Next COVID-19 and conduct: social media warning

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous ‘Very, very lengthy delay’ torpedoes unfair dismissal case

Next COVID-19 and conduct: social media warning

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.